全球髓內髖螺釘市場：市場規模、佔有率和趨勢分析（2025-2031 年）

2024年全球髓內髖螺釘市場價值為11億美元。預計該市場將持續成長，到2031年將達到13億美元。

本報告涵蓋全球髓內髖螺釘市場的所有產品細分市場，包括鈦合金和不銹鋼髓內髖螺釘。報告量化了銷量、平均售價（ASP）、市場規模、成長率和企業市場占有率。此外，報告還分析了市場促進因素和限制因素、近期併購、手術技術趨勢和技術發展。本研究提供截至2021年的歷史資料以及截至2031年的預測資料。

市場概覽

髓內髖螺釘已成為股骨粗隆間和粗隆下骨折內固定的全球標準。其動態設計提供了卓越的穩定性，與傳統髖螺釘相比，可使患者更早活動並促進骨折癒合。髓內固定的持續普及反映了外科醫生對這些系統臨床可靠性和良好治療效果日益成長的信心。

全球市場受人口老化導致髖部骨折發生率上升的驅動，尤其是在北美、歐洲和亞太部分地區。老年患者容易發生低能量損傷和脆性骨折，而這些損傷和骨折仍是造成老年患者發病率和醫療成本的主要原因。醫院和創傷中心持續優先採用兼具強度、可重複性和低併發症率的醫療器材。

與鋼板固定相比，髓內螺釘具有更高的旋轉穩定性、更均勻的軸向負載分佈和更可控的骨折加壓效果。這些優勢降低了再次手術率和術後併發症，使其在已開發市場和新興市場中持續應用。

材料成分仍然是採購決策的核心因素。鈦合金髓內螺絲因其重量輕、生物相容性好、耐腐蝕和抗疲勞等優點而佔據市場主導地位。主要製造商持續加大研發投入，推動新型鈦合金的開發，進而提供更高的強度和耐久性。不銹鋼螺絲在高負荷應用和對成本敏感的市場中仍然使用，但隨著鈦合金系統價格的降低，其市場佔有率正在逐漸下降。

在全球範圍內，IM髖螺釘市場受益於其在創傷護理中的關鍵作用，創傷護理是一種緊急手術，無論經濟狀況如何都需要進行，這一特點穩定了需求並限制了宏觀經濟衰退的影響。

市場促進因素

髓內螺絲越來越受歡迎

過去十年間，股骨近端骨折的治療標準已從鋼板和傳統螺絲固定轉向髓內髖關節螺釘固定。這些系統兼具強度、穩定性和可控骨折加壓的優點，使患者能夠早期負重並促進復原。

儘管骨內螺釘的平均售價通常高於傳統固定方法，但其顯著改善的臨床療效足以證明其成本合理。由於再次手術率更低、住院時間更短，醫院越來越認可骨內螺釘是治療股骨粗隆間骨折和股骨粗隆下骨折最具成本效益的選擇。

植入幾何形狀、鎖定機制和器械的不斷改進進一步增強了這種臨床偏好。現代設計提高了植入精度，縮短了手術時間，並降低了術中骨折和器械故障的風險。隨著培訓計畫和整形外科課程越來越重視髓內固定技術，該手術在該地區的應用也持續成長。

在基本外科手術中的作用

股骨近端創傷性骨折和脆弱性骨折需在急診手術中透過股骨內螺釘治療。由於此類手術的緊急性，儘管經濟週期波動和醫院資本預算變化，其需求仍保持穩定。

由於髖部骨折治療的必要性，手術數量與人口因素密切相關，而非可支配支出。隨著全球預期壽命的延長和人口老化，髖部骨折的發生率預計將穩定上升，尤其是在醫療體系成熟的地區。這一人口趨勢支撐了髖關節內螺釘市場的長期需求穩定性。

良好的臨床結果

臨床研究一致表明，對於股骨內側和股骨粗隆下骨折，髓內髖關節螺釘固定優於傳統固定方法。髓內植入的負荷分擔結構允許早期活動，從而改善復健效果並降低併發症發生率。

這種設計允許在骨折部位進行可控滑動，促進自然加壓，並降低植入失效的風險。這種動態優勢使得髓內螺釘在世界各地的許多醫院幾乎完全取代了傳統的髖關節螺釘系統。隨著降低再次手術率的數據不斷積累，外科醫生繼續選擇髓內螺釘，因為它們具有可靠性和長期療效。

市場限制

平均售價（ASP）下降

儘管手術量保持穩定，但整形外科創傷植入的平均售價仍持續受到集團採購組織 (GPO)、政府採購和基於價值的採購舉措的壓力。這些採購模式集中需求並優先考慮價格競爭，削弱了製造商維持高價的能力，即使在特殊植入領域也是如此。

中國等地區在2021年實施國家採購政策後，價格出現了顯著下降。西歐和北美也出現了類似的趨勢，當地醫院正利用集體談判來協商產品標準化和批量折扣。隨著時間的推移，儘管採購量持續成長，但這種趨勢將限制價格成長。

髖關節置換術的發展

關節重組技術的進步對髖關節髓內螺釘構成了間接競爭。由於植入材料的改進、模組化設計的運用以及手術技術的精進，全髖關節置換和部分置換術的可靠性置換術提高。

隨著關節置換療效的提高，一些外科醫生在治療複雜骨折時，尤其是對於患有骨質疏鬆症且功能預後較差的老年患者，傾向於選擇全髖置換術而非內固定。這種臨床轉變可能會導致接受內固定螺絲治療的患者群體縮小，尤其是在擁有先進關節置換技術的三級醫療中心。

雖然髓內螺釘仍然是治療大多數股骨粗隆間骨折的標準方法，但老年人髖關節置換術置換術的長期趨勢阻礙因素了其發展。

手術併發症

儘管骨內螺絲可提供優異的力學效果，但其植入需要更高的手術精度和經驗。植入點和軌跡必須經過仔細規劃，並且在植入螺絲前必須達到充分的骨折復位。與傳統螺絲系統相比，這些步驟增加了手術時間和複雜性。

此外，接受股骨髓內釘固定的患者可能會出現術後大腿疼痛，尤其是在使用兩枚遠端鎖定螺釘或髓內釘延伸至股骨幹的情況下。雖然這些併發症是可以控制的，但外科醫師在選擇固定方案時仍需考慮這些因素。

儘管培訓計劃和設備的改進正在緩解這些挑戰，但手術的複雜性仍然是資源有限的醫院廣泛採用該手術的障礙。

目標市場和數據範圍

• 目標時期：基準年2024年，預測期間2025-2031年，歷史資料2021-2023年
• 醫療機構：醫院、創傷中心、整形外科手術中心
• 調查方法：市場價值透過銷售量乘以平均售價（ASP）計算得出，並透過手術量、醫院採購數據和進出口記錄進行檢驗。

市場區隔摘要

• 髓內髖螺釘市場－進一步細分為以下幾個部分：
• 按材質：不鏽鋼和鈦
• 量化指標：市場規模、市佔率、預測、成長率、銷售量、平均售價。
• 定性內容：市場成長趨勢、市場限制、主要競爭對手的競爭和 SWOT 分析、併購、公司簡介、產品系列、顛覆性技術、疾病概況。
• 資料來源：對行業領導者的直接訪談、監管和政府資料、醫院採購記錄以及 iData Research 的內部資料庫。

競爭分析

史賽克

2024年，史賽克公司在全球髓內髖關節螺釘市場佔據領先地位。該公司的Gamma®髓內釘系統長期以來因其重新定義股骨近端骨折的治療方法並推動市場擺脫傳統髖螺釘的束縛而備受認可。 Gamma®產品系列強大的臨床應用記錄、廣泛的全球供應鏈以及精簡的器械，鞏固了其持續的領先地位。史賽克公司與創傷中心和分銷商建立了牢固的合作關係，進一步強化了其市場領先地位。

德普合成公司

DePuy Synthes憑藉其全面的產品組合，包括PFNA®、TFN®和TFNA®（鈦合金股骨大轉子鎖定髓內釘高級版）系統，在全球市場佔有率排名第二。這些器械旨在為股骨近端骨折提供可靠的固定和可控的加壓。 DePuy Synthes受益於值得信賴的品牌、豐富的臨床數據以及與包括鋼板、螺絲和髓內系統在內的廣泛創傷產品組合的整合。對創新鈦基技術的持續投資預計將進一步推動市場佔有率的擴大。

史密斯和內夫

史密斯-內普公司（Smith & Nephew）佔據髓內髖螺釘市場第三大佔有率，主要歸功於其TRIGEN INTERTAN®前股骨大轉子固定釘。這種雙螺絲整合系統可對骨折進行可控加壓固定，並提高旋轉穩定性。該公司成長較為穩健，而TRIGEN INTERTAN®系統憑藉其可靠性和廣泛應用，為其在高度集中的市場中保持穩定的佔有率奠定了基礎。

技術與臨床實務的趨勢

• 鈦合金創新：對鈦合金和混合合金的持續研究和開發提高了抗疲勞性和植入耐久性。
• 短釘：短釘結構可減輕股骨幹的壓力，進而減少大腿疼痛的發生率。
• 先進的鎖定機構：多向鎖定系統提供更高的旋轉和軸向穩定性。
• 改良的器械：符合人體工學的目標定位裝置和擴孔器簡化了手術流程，縮短了手術時間。
• 微創技術：經皮方法和改進的標靶裝置可減少組織損傷和出血。
• 術後鎮痛：新設計旨在透過最佳化遠端鎖定結構來減輕大腿疼痛。

附錄簡稱調查方法。

目錄

圖表清單

圖表列表

調查方法

全球關稅的影響

髓內髖關節螺絲市場

• 執行摘要
  • 全球髓內髖螺釘市場概覽
  • 競爭分析
  • 流程分段
  • 市場區隔
  • 目標區域
• 介紹
• 手術次數
  • 全髖關節髓內螺絲手術
• 市場概覽
  • 按細分市場
  • 按地區
• 市場分析與預測
  • 全髖關節髓內螺絲市場
  • 不銹鋼髓內髖關節螺絲市場
  • 鈦合金髓內髖螺釘市場
• 駕駛員和約束裝置
• 競爭市佔率分析

簡稱

The global intramedullary (IM) hip screw market was valued at $1.1 billion in 2024. The market is projected to grow, reaching $1.3 billion by 2031.

This report covers the full suite of products in the global IM hip screw market, including titanium and stainless-steel IM hip screws. It quantifies unit sales, average selling prices (ASPs), market values, growth rates, and company shares, and analyzes market drivers and limiters, recent mergers and acquisitions, procedure trends, and technology developments. The study provides historical data to 2021 and forecasts through 2031.

Market Overview

Intramedullary hip screws have become the global standard for internal fixation of intertrochanteric and subtrochanteric fractures of the femur. Their biomechanical design provides superior stability, allowing earlier patient mobilization and improved fracture healing compared to conventional hip screw constructs. The continued shift toward intramedullary fixation reflects growing confidence among surgeons in the clinical reliability and favorable outcomes of these systems.

The global market is driven by increasing hip fracture incidence due to aging populations, particularly in North America, Europe, and parts of Asia-Pacific. Elderly patients are more prone to low-energy trauma and fragility fractures, which remain a major cause of morbidity and healthcare cost. Hospitals and trauma centers continue to prioritize devices that combine strength, reproducibility, and reduced complication rates.

Compared with plate-based fixation, IM hip screws provide enhanced rotational stability, axial load distribution, and controlled fracture impaction. These features reduce reoperation rates and postoperative complications, which supports continued adoption across developed and emerging markets.

Material composition remains a central factor in purchasing decisions. Titanium IM screws dominate the market because of their light weight, biocompatibility, and resistance to corrosion and fatigue. New titanium alloys are under development to further enhance strength and durability, reflecting ongoing R&D investment from major manufacturers. Stainless steel screws retain use in high-load cases and cost-sensitive markets but are gradually losing share as titanium systems become more affordable.

Globally, the IM hip screw market benefits from its essential role in trauma care, where procedures are non-elective and must proceed regardless of economic conditions. This dynamic stabilizes demand and limits exposure to macroeconomic downturns.

Market Drivers

Growth in Popularity of Intramedullary Screws

Over the past decade, treatment standards for proximal femoral fractures have shifted decisively from plate and conventional screw constructs toward intramedullary hip screws. These systems offer a superior combination of strength, stability, and controlled fracture compression, enabling patients to bear weight earlier and recover faster.

Although IM hip screws typically carry a higher ASP than conventional constructs, the improved clinical outcomes justify their cost. Hospitals increasingly view them as the most cost-effective option for managing intertrochanteric and subtrochanteric fractures due to reduced reoperation rates and shorter hospital stays.

This clinical preference is reinforced by continuous refinement of implant geometry, locking mechanisms, and instrumentation. Modern designs improve insertion accuracy, reduce operative time, and decrease the risk of intraoperative fracture or hardware failure. As training programs and orthopedic curricula emphasize IM fixation techniques, procedural adoption continues to rise across all regions.

Role in Essential Surgery

IM hip screws are used in non-elective surgeries that address traumatic or fragility fractures of the proximal femur. Because these procedures are urgent, demand remains steady regardless of economic cycles or changes in hospital capital budgets.

The essential nature of hip fracture treatment means that procedural volumes are closely tied to demographic factors rather than discretionary spending. As global life expectancy rises and populations age, the frequency of hip fractures is expected to increase steadily, particularly in regions with mature healthcare systems. This demographic trend underpins long-term demand stability in the IM hip screw market.

Favorable Clinical Outcomes

Clinical research consistently demonstrates that IM hip screws outperform traditional fixation methods for intertrochanteric and subtrochanteric fractures. The intramedullary placement provides a load-sharing construct that allows early mobilization, leading to improved rehabilitation and lower complication rates.

The design enables controlled sliding at the fracture site, facilitating natural compression and reducing the risk of implant failure. This biomechanical advantage explains why IM hip screws have almost completely replaced conventional hip screw systems in many hospitals worldwide. As data on reduced reoperation rates accumulate, surgeons continue to prefer IM constructs for their reliability and long-term performance.

Market Limiters

ASP Decreases

Despite stable procedural demand, ASPs for orthopedic trauma implants remain under pressure from group purchasing organizations (GPOs), government tenders, and value-based procurement initiatives. These purchasing models aggregate demand and prioritize price competition, reducing the ability of manufacturers to sustain premiums even in specialized implant categories.

Regions such as China have seen particularly steep price declines following the rollout of national procurement policies in 2021. Similar dynamics affect Western Europe and North America, where hospitals leverage collective bargaining to standardize products and negotiate volume discounts. Over time, this trend limits value growth despite consistent unit expansion.

Growth of Hip Replacement

Advances in joint reconstruction are creating indirect competition for IM hip screws. Total and partial hip replacements have become increasingly reliable, with improved implant materials, modular designs, and refined surgical techniques.

As outcomes for arthroplasty procedures improve, some surgeons prefer hip replacement over internal fixation for complex fractures, particularly in elderly patients with osteoporotic bone or poor functional prognosis. This clinical shift reduces the potential pool of candidates for IM screw fixation, particularly in tertiary care centers with high arthroplasty expertise.

Although IM screws remain the standard for most intertrochanteric fractures, the long-term trend toward greater use of hip replacements in elderly populations represents a limiting factor for growth.

Increased Surgical Complexity

While IM hip screws deliver superior mechanical results, their insertion requires greater surgical precision and experience. The entry point and trajectory must be carefully planned, and proper fracture reduction must be achieved before nail insertion. These steps add time and complexity to the operation compared to conventional hip screw systems.

Additionally, patients implanted with IM hip nails may experience postoperative thigh pain, especially when constructs use two distal locking screws or when the nail extends into the diaphysis. Although such complications are manageable, they remain a consideration when surgeons evaluate fixation options.

Training programs and improved instrumentation continue to mitigate these challenges, but surgical complexity remains a barrier to universal adoption in lower-resource hospitals.

Market Coverage and Data Scope

• Time Frame: Base year 2024, forecasts 2025-2031, and historical data 2021-2023.
• Care Settings: Hospitals, trauma centers, and orthopedic surgical facilities.
• Methodology: Market values derived from unit sales X ASP, validated through procedure volumes, hospital purchasing data, and import/export records.

Market Segmentation Summary

• Intramedullary Hip Screw Market - Further Segmented Into:
• Material Type: Stainless Steel and Titanium
• Quantitative Coverage: Market size, market shares, forecasts, growth rates, units sold, and average selling prices.
• Qualitative Coverage: Market growth trends, market limiters, competitive analysis and SWOT for top competitors, mergers and acquisitions, company profiles, product portfolios, disruptive technologies, and disease overviews.
• Data Sources: Primary interviews with industry leaders, regulatory and government data, hospital procurement records, and iData Research's internal database.

Competitive Analysis

Stryker

Stryker was the leading company in the global intramedullary hip screw market in 2024. The company's Gamma(R) Nail System has long been recognized for redefining the treatment of proximal femoral fractures and shifting the market away from conventional hip screws. The Gamma(R) portfolio's strong clinical record, combined with broad global availability and streamlined instrumentation, ensures continued leadership. Stryker's established relationships with trauma centers and distributors reinforce its position at the top of the market.

DePuy Synthes

DePuy Synthes ranked second globally, supported by its comprehensive product suite, including the PFNA(R), TFN(R), and TFNA(R) (Titanium Trochanteric Fixation Nail Advanced) systems. These devices are designed for reliable fixation and controlled compression in proximal femoral fractures. DePuy Synthes benefits from brand trust, extensive clinical documentation, and integration with its broader trauma portfolio, which includes plates, screws, and intramedullary systems. Continued investment in titanium-based innovations is expected to support incremental market share gains.

Smith & Nephew

Smith & Nephew held the third-largest share in the IM hip screw market, primarily through its TRIGEN INTERTAN(R) Intertrochanteric Antegrade Nail. This dual integrated screw system allows controlled fracture impaction and enhanced rotational stability. While Smith & Nephew's growth has been modest, the TRIGEN INTERTAN(R) remains a reliable and widely used system that supports a stable share position in a highly consolidated market.

Technology and Practice Trends

• Titanium Alloy Innovation: Ongoing R&D in titanium and hybrid alloys improves fatigue resistance and implant longevity.
• Shorter Nails: Shorter constructs reduce stress on the femoral shaft and lower thigh pain rates.
• Advanced Locking Options: Multidirectional locking systems enhance rotational and axial stability.
• Instrumentation Upgrades: Ergonomic targeting devices and reamers streamline procedures and reduce operating time.
• Minimally Invasive Techniques: Percutaneous approaches and improved targeting reduce tissue trauma and blood loss.
• Postoperative Pain Reduction: New designs aim to mitigate thigh pain through optimized distal locking configurations.

Methodology Appendix and Acronym Glossary included.

Why This Report

Where are the largest and fastest-growing regions within the global IM hip screw market through 2031.

How titanium innovation and material shifts are shaping product design, cost, and competitiveness.

Which companies are leading and how their portfolios compare by feature, reach, and performance.

How GPOs, tenders, and procurement models influence pricing and adoption.

How hip replacement trends are impacting fracture fixation decisions and patient management.

What design innovations reduce operative complexity and postoperative complications.

The Global Intramedullary Hip Screw Market Report from iData Research answers these questions with device-level analysis, company share tracking, and pricing benchmarks.

It enables stakeholders to quantify demand, evaluate competition, and plan commercial strategy across material and regional segments.

TABLE OF CONTENT

Table Of Contents

List Of Figures

List Of Charts

Research Methodology

• Step 1: Project Initiation & Team Selection
• Step 2: Prepare Data Systems And Perform Secondary Research
• Step 3: Preparation For Interviews & Questionnaire Design
• Step 4: Performing Primary Research
• Step 5: Research Analysis: Establishing Baseline Estimates
• Step 6: Market Forecast And Analysis
• Step 7: Identify Strategic Opportunities
• Step 8: Final Review And Market Release
• Step 9: Customer Feedback And Market Monitoring

Impact Of Global Tariffs

Intramedullary Hip Screw Market

• 8.1 Executive Summary
  • 8.1.1 Global Intramedullary Hip Screw Market Overview
  • 8.1.2 Competitive Analysis
  • 8.1.3 Procedure Segmentation
  • 8.1.4 Market Segmentation
  • 8.1.5 Regions Included
• 8.2 Introduction
• 8.3 Procedure Numbers
  • 8.3.1 Total Intramedullary Hip Screw Procedures
• 8.4 Market Overview
  • 8.4.1 By Segment
  • 8.4.2 By Region
• 8.5 Market Analysis And Forecast
  • 8.5.1 Total Intramedullary Hip Screw Market
  • 8.5.2 Stainless-Steel Intramedullary Hip Screw Market
  • 8.5.3 Titanium Intramedullary Hip Screw Market
• 8.6 Drivers And Limiters
  • 8.6.1 Market Drivers
  • 8.6.2 Market Limiters
• 8.7 Competitive Market Share Analysis

Abbreviations

LIST OF CHARTS

• Chart 8-1: Intramedullary Hip Screw Market, Global, 2024 & 2031
• Chart 8-2: Intramedullary Hip Screw Procedures, Global, 2024
• Chart 8-3: Intramedullary Hip Screw Procedures by Region, Global, 2021 - 2031
• Chart 8-4: Intramedullary Hip Screw Market by Segment, Global, 2021 - 2031
• Chart 8-5: Intramedullary Hip Screw Market by Region, Global, 2021 - 2031
• Chart 8-6: Leading Competitors, Intramedullary Hip Screw Market, Global, 2024

LIST OF FIGURES

• Figure 8-1: Intramedullary Hip Screw Procedure Segmentation
• Figure 8-2: Intramedullary Hip Screw Market Segmentation
• Figure 8-3: Intramedullary Hip Screw Regions Covered, Global (1 of 2)
• Figure 8-4: Intramedullary Hip Screw Regions Covered, Global (2 of 2)
• Figure 8-5: Intramedullary Hip Screw Procedures by Region, Global, 2021 - 2031
• Figure 8-6: Intramedullary Hip Screw Procedures by Country, North America, 2021 - 2031
• Figure 8-7: Intramedullary Hip Screw Procedures by Country, Latin America, 2021 - 2031 (1 of 2)
• Figure 8-8: Intramedullary Hip Screw Procedures by Country, Latin America, 2021 - 2031 (2 of 2)
• Figure 8-9: Intramedullary Hip Screw Procedures by Country, Western Europe, 2021 - 2031
• Figure 8-10: Intramedullary Hip Screw Procedures by Country, Central & Eastern Europe, 2021 - 2031 (1 of 2)
• Figure 8-11: Intramedullary Hip Screw Procedures by Country, Central & Eastern Europe, 2021 - 2031 (2 of 2)
• Figure 8-12: Intramedullary Hip Screw Procedures by Country, Middle East, 2021 - 2031
• Figure 8-13: Intramedullary Hip Screw Procedures by Country, Asia-Pacific, 2021 - 2031 (1 of 3)
• Figure 8-14: Intramedullary Hip Screw Procedures by Country, Asia-Pacific, 2021 - 2031 (2 of 3)
• Figure 8-15: Intramedullary Hip Screw Procedures by Country, Asia-Pacific, 2021 - 2031 (3 of 3)
• Figure 8-16: Intramedullary Hip Screw Procedures by Country, Africa, 2021 - 2031
• Figure 8-17: Intramedullary Hip Screw Market by Segment, Global, 2021 - 2031 (US$M)
• Figure 8-18: Intramedullary Hip Screw Market by Region, Global, 2021 - 2031 (US$M)
• Figure 8-19: Intramedullary Hip Screw Market, Global, 2021 - 2031
• Figure 8-20: Units Sold by Region, Intramedullary Hip Screw Market, Global, 2021 - 2031
• Figure 8-21: Average Selling Price by Region, Intramedullary Hip Screw Market, Global, 2021 - 2031 (US$)
• Figure 8-22: Market Value by Region, Intramedullary Hip Screw Market, Global, 2021 - 2031 (US$M)
• Figure 8-23: Stainless-Steel Intramedullary Hip Screw Market, Global, 2021 - 2031
• Figure 8-24: Units Sold by Region, Stainless-Steel Intramedullary Hip Screw Market, Global, 2021 - 2031
• Figure 8-25: Average Selling Price by Region, Stainless-Steel Intramedullary Hip Screw Market, Global, 2021 - 2031 (US$)
• Figure 8-26: Market Value by Region, Stainless-Steel Intramedullary Hip Screw Market, Global, 2021 - 2031 (US$M)
• Figure 8-27: Titanium Intramedullary Hip Screw Market, Global, 2021 - 2031
• Figure 8-28: Units Sold by Region, Titanium Intramedullary Hip Screw Market, Global, 2021 - 2031
• Figure 8-29: Average Selling Price by Region, Titanium Intramedullary Hip Screw Market, Global, 2021 - 2031 (US$)
• Figure 8-30: Market Value by Region, Titanium Intramedullary Hip Screw Market, Global, 2021 - 2031 (US$M)
• Figure 8-31: Leading Competitors, Intramedullary Hip Screw Market, Global, 2024